When Treating Sick Joints Harms Lungs, Ixekizumab induced Pleural Effusion

Authors

Rami Batarseh, Joan C Edwards School of Medicine / Marshall UniversityFollow
Kyle Smith, Joan C Edwards School of medicine, Marshall UniversityFollow
Mohammed Al-Ourani, Marshall UniversityFollow
Amro K. Al-Astal, Marshall University Joan C. Edwards School of MedicineFollow

Author Credentials

Rami Batarseh MD Kyle Smith MD Mohammed Al-Ourani MD Amro K. Al-Astal MD

Keywords

Ixekizumab, Pleural effusion, pleuritis, Immune Therapy

Disciplines

Biological Factors | Internal Medicine | Medicine and Health Sciences | Pulmonology | Rheumatology

Abstract

Immunological therapies have provided a multitude of new and effective treatment strategies for various disease states. While monoclonal antibody therapy benefits many patients, side effects are widely variable. here we present a case of pleural effusion complicating psoriatic arthritis treatment.

Recommended Citation

Batarseh R, Smith K, Al-Ourani M, Al-Astal AK. When Treating Sick Joints Harms Lungs, Ixekizumab induced Pleural Effusion. Marshall J Med. 2020; 6(2): 41 DOI: https://doi.org/10.33470/2379-9536.1262.